Viveve Medical, Inc. (VIVE): Price and Financial Metrics

Viveve Medical, Inc. (VIVE): $0.64

-0.02 (-3.19%)

POWR Rating

Component Grades













VIVE Stock Summary

  • With a market capitalization of $10,513,648, Viveve Medical Inc has a greater market value than only 0.94% of US stocks.
  • The volatility of Viveve Medical Inc's share price is greater than that of 92.06% US stocks with at least 200 days of trading history.
  • Viveve Medical Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -247.71%, greater than the shareholder yield of only 1.16% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Viveve Medical Inc, a group of peers worth examining would be GBT, CERS, BLI, QUIK, and PDEX.
  • Visit VIVE's SEC page to see the company's official filings. To visit the company's web site, go to

VIVE Valuation Summary

  • VIVE's price/sales ratio is 4.5; this is 18.42% higher than that of the median Healthcare stock.
  • VIVE's price/sales ratio has moved up 3.7 over the prior 138 months.
  • Over the past 138 months, VIVE's price/sales ratio has gone up 3.7.

Below are key valuation metrics over time for VIVE.

Stock Date P/S P/B P/E EV/EBIT
VIVE 2021-08-31 4.5 1.2 -1.3 -0.5
VIVE 2021-08-30 4.3 1.1 -1.3 -0.5
VIVE 2021-08-27 4.2 1.1 -1.2 -0.4
VIVE 2021-08-26 4.2 1.1 -1.2 -0.4
VIVE 2021-08-25 4.3 1.1 -1.2 -0.4
VIVE 2021-08-24 4.0 1.0 -1.2 -0.3

VIVE Growth Metrics

    The year over year net income to common stockholders growth rate now stands at 36.1%.
  • Its 2 year cash and equivalents growth rate is now at -76.44%.
  • Its 4 year price growth rate is now at -99.91%.
VIVE's revenue has moved up $3,733,000 over the prior 70 months.

The table below shows VIVE's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 6.426 -12.878 -26.718
2021-09-30 6.667 -11.949 -24.967
2021-06-30 6.575 -12.033 -22.707
2021-03-31 5.625 -12.751 -25.674
2020-12-31 5.479 -15.234 -26.064
2020-09-30 4.983 -18.31 -35.42

VIVE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • VIVE has a Quality Grade of F, ranking ahead of 4.15% of graded US stocks.
  • VIVE's asset turnover comes in at 0.243 -- ranking 139th of 186 Medical Equipment stocks.
  • PETV, INO, and POAI are the stocks whose asset turnover ratios are most correlated with VIVE.

The table below shows VIVE's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.243 0.157 -1.501
2021-03-31 0.237 0.089 -1.678
2020-12-31 0.279 0.054 -1.690
2020-09-30 0.224 -0.014 -2.471
2020-06-30 0.194 -0.079 -1.758
2020-03-31 0.198 0.025 -1.358

VIVE Price Target

For more insight on analysts targets of VIVE, see our VIVE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $9.63 Average Broker Recommendation 1.25 (Strong Buy)

VIVE Stock Price Chart Interactive Chart >

Price chart for VIVE

VIVE Price/Volume Stats

Current price $0.64 52-week high $3.08
Prev. close $0.66 52-week low $0.61
Day low $0.62 Volume 87,400
Day high $0.66 Avg. volume 186,163
50-day MA $0.79 Dividend yield N/A
200-day MA $1.30 Market Cap 6.76M

Viveve Medical, Inc. (VIVE) Company Bio

Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal laxity. The company was founded in 2005 and is based in Sunnyvale, California.

VIVE Latest News Stream

Event/Time News Detail
Loading, please wait...

VIVE Latest Social Stream

Loading social stream, please wait...

View Full VIVE Social Stream

Latest VIVE News From Around the Web

Below are the latest news stories about Viveve Medical Inc that investors may wish to consider to help them evaluate VIVE as an investment opportunity.

Healthcare Technology Report Names Viveve Regulatory Executive Among Top 25 Women Leaders in Medical Devices

Viveve SVP Suzon Lommel named to list for second consecutive year for efforts to advance innovative technologies to treat stress urinary incontinence in womenENGLEWOOD, CO / ACCESSWIRE / January 13, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, announced today that Suzon Lommel, the Company's Senior Vice President of Regulatory and Quality Affairs, has been named by The Healthcare Technology Report as one of The Top 25 Women Leaders i

Yahoo | January 13, 2022

Viveve to Participate in H.C. Wainwright BIOCONNECT Conference

ENGLEWOOD, CO / ACCESSWIRE / January 4, 2022/ Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health, today announced that Scott Durbin, chief executive officer, will participate in the H.

Yahoo | January 4, 2022

Viveve Medical, Inc. (NASDAQ:VIVE) Short Interest Update

Viveve Medical, Inc. (NASDAQ:VIVE) was the recipient of a large drop in short interest during the month of November. As of November 30th, there was short interest totalling 300,500 shares, a drop of 26.1% from the November 15th total of 406,400 shares. Approximately 3.0% of the shares of the company are sold short. Based on []

Transcript Daily | December 18, 2021

Viveve Medical, Inc.: Viveve Announces Completion of Full Enrollment in Pivotal U.S. PURSUIT Trial for Stress Urinary Incontinence

Major milestone achieved in Company''s advance toward a new U.S. SUI indicationENGLEWOOD, CO / ACCESSWIRE / December 14, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focus

FinanzNachrichten | December 14, 2021

Viveve Announces Completion of Full Enrollment in Pivotal U.S. PURSUIT Trial for Stress Urinary Incontinence

Major milestone achieved in Company's advance toward a new U. SUI indicationENGLEWOOD, CO / ACCESSWIRE / December 14, 2021 / Viveve Medical, Inc.

Yahoo | December 14, 2021

Read More 'VIVE' Stories Here

VIVE Price Returns

1-mo -13.51%
3-mo -40.19%
6-mo -48.39%
1-year -76.81%
3-year -99.82%
5-year -99.99%
YTD -43.86%
2021 -75.74%
2020 -62.70%
2019 -98.80%
2018 -78.87%
2017 -3.50%

Continue Researching VIVE

Want to see what other sources are saying about Viveve Medical Inc's financials and stock price? Try the links below:

Viveve Medical Inc (VIVE) Stock Price | Nasdaq
Viveve Medical Inc (VIVE) Stock Quote, History and News - Yahoo Finance
Viveve Medical Inc (VIVE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4977 seconds.